Patent ID: 11951147
Assignee: MEDIVIR AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 16:
17. The method of claim 12, wherein the cancer cell is an adrenocortical carcinoma cell, anal cancer cell, astrocytoma cell, bladder cancer cell, bone cancer cell, breast cancer cell, cervical cancer cell, colon cancer cell, endocrine cancer cell, endometrial cancer cell, ependymoma cell, esophageal cancer cell, Ewing's sarcoma cell, extrahepatic bile duct cancer cell, gallbladder cancer cell, gastric cancer cell, glioblastoma cell, glioma cell, head and neck cancer cell, Hodgkin lymphoma cell, hypopharyngeal cancer cell, intraocular melanoma cell, islet cell carcinoma cell, Kaposi sarcoma cell, laryngeal cancer cell, leukemia cell, lip cancer cell, liver cancer cell, lung adenocarcinoma cell, medulloblastoma cell, melanoma cell, meningioma cell, Merkel cell carcinoma cell, mesothelioma cell, multiple myeloma cell, nasopharyngeal cancer cell, neuroblastoma cell, non-Hodgkin lymphoma cell, non-small cell lung cancer cell, oral cavity cancer cell, oropharyngeal cancer cell, ovarian cancer cell, pancreatic cancer cell, paranasal sinus cancer cell, parathyroid cancer cell, penile cancer cell, peripheral neuroma cell, pheochromocytoma cell, pineoblastoma cell, pituitary tumor cell, prostate cancer cell, rectal cancer cell, renal cell cancer cell, retinoblastoma cell, rhabdomyosarcoma cell, salivary gland cancer cell, skin cancer cell, small cell lung cancer cell, small intestine cancer cell, soft tissue sarcoma cell, testicular cancer cell, thymic carcinoma cell, thymoma cell, thyroid cancer cell, urethral cancer cell, uterine sarcoma cell, vaginal cancer cell, vulvar cancer cell, or a Wilm's tumor cell.